Japanese pharmaceutical firm Astellas Pharma has named Songlin Hue as Head of Global Pharmacovigilance. He will be located at Astellas’ headquarters for the Americas in Northbrook, Illinois, US and report to Sef Kurstjens, who recently became Chief Medical Officer at the company.
Astellas has now hired global heads in the areas of Pharmacovigilance, Medical Affairs, Regulatory Affairs, Clinical and Research Quality Assurance, and Quality Assurance.
In more than 20 years in the pharmaceutical industry, Xue has held increasingly senior roles with global responsibilities in drug safety and pharmacoepidemiology. Most recently, he was Senior Vice President, Head of Global Pharmacovigilance at Takeda Pharmaceuticals.
Prior to joining Takeda, Xue held posts at global pharmaceutical companies such as Novartis and Wyeth.
